Summary
Chief cell mass and type I serum pepsinogen (PGI) were calculated in 19 advanced antral gastric cancer of intestinal type. Comparisons were also made with parietal cell mass and acid secretion. In gastric cancer of the antrum there is a significant decrease of the chief cell mass and of serum pepsinogen I. The patients were subdivided according to the histological findings of the fundic mucosa. In cases of antral gastric cancer with superficial fundic gastritis there is normozymogenism with hyperpepsinogenemy; with preatrophic fundic gastritis there is hypozymogenism with normopepsinogenemy; with atrophic fundic gastritis there is hypozymogenism with hypopepsinogenemy. Similar behavior of the chief cell mass between antral gastric cancer and fundic atrophic gastritis without cancer has become recognized and while the validity of PGI as a marker of fundic atrophic gastritis has emerged it does not allow discrimination between atrophic fundic gastritis and atrophic fundic gastritis associated with gastric cancer of the antrum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Spiro HM, Ryan AE, Jones CM: The relation of blood pepsin to gastric secretion, with particular reference to anacidity and achylia. Gastroenterology 1956;30:563–579.
Pasture YO, Hiroo K, Belsky YL: Serum pepsin and tubeless gastric analysis as predictors of stomach cancer. N Engl J Med 1972:286:279–284.
Nomura MAY, Stemmerman GN, Samloff IM: Serum pepsinogen I as a predictor of stomach cancer. Am Int Med 1980;93: 537–540.
Stemmerman GN, Hayashi T, Samloff IM: Pepsinogen I and II in carcinoma of the stomach. Gastroenterology 1984:86:1266.
Reid WA, Thompson D, Kay Y: Pepsinogen in gastric carcinoma cells. J Clin Pathol 1983:36:137–139.
Fiocca R, Cornaggia M, Villani L, et al: Expression of pepsinogen II in gastric cancer. Cancer 1988;61:956–962.
Farinati F, Di Mario F, Plebani M, et al: Decreased PGA/PGC ratio in patients with gastric cancer or gastric precancerous condition. Ital J Gastroenterol 1990:22:245.
Perasso A, Testino G, De Angelis P, et al: Chief cell mass in normal gastric mucosa: relationship with serum pcpsinogen I. Gastroenterologie Clinique et Biologique 1990;14:158–162.
Perasso A, Testino G, De Angelis P, et al: Gastric chief cell mass in chronic gastritis. Count and relationships with parietal cell mass and functional indices. Hepato-Gastroenterol; in press.
Cheli R: Workshop on the histo morphology of chronic gastritisGenoa 1982. Ital J Gastroenterol 1983;15:206.
Cheli R, Perasso A, Giacosa A: Gastritis. A critical Review. Springer Verlag, Berlin, Heidelberg. 1987.
Perasso A, Testino G, De AngelisP: Evaluation quantitative des cellules principales (zymogenes) dans la muqueuse normale de l’estomac. Annales de Gastrenterologie et d’Hepatologie 1987;22:166.
Lauren P: The two histological main types of gastric carcinoma: diffuse and so called intestinal type carcinoma. Acta Pathol Microbiol Scand 1965;64:31.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perasso, A., Testino, G. Advanced gastric cancer of the antrum: Anatomic-functional correlation between chief cell mass and serum pepsinogen I. Gastroenterol Jpn 26, 588–592 (1991). https://doi.org/10.1007/BF02781674
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02781674